Skip to main content

Table 1 Relationship of high SESN2 expression with clinicopathological characteristics in HCC

From: SESN2 correlates with advantageous prognosis in hepatocellular carcinoma

Groups

No.

SESN2

χ 2

p value

+

%

Gender

 Male

83

31

37.3

0.088

0.767

 Female

17

7

41.2

  

Age (years)

  < 60

58

18

31.0

2.844

0.092

  ≥ 60

42

20

47.6

  

Hepatitis B virus infection

 Positive

41

10

24.4

5.463

0.019*

 Negative

59

28

47.5

  

Hepatitis C virus infection

 Positive

52

31

59.6

21.484

0.001*

 Negative

48

7

14.6

  

Liver cirrhosis

 Positive

58

21

36.2

0.189

0.664

 Negative

42

17

40.5

  

Tumor size (cm)

  > 5

57

19

33.3

1.225

0.268

  ≤ 5

43

19

44.2

  

Lymph node metastasis

 Positive

31

7

22.6

4.534

0.033*

 Negative

69

31

44.9

  

Distant metastasis

 Positive

12

4

33.3

0.126

0.723

 Negative

88

34

38.6

  

TNM stage

 Stage I-II

41

17

41.5

0.354

0.552

 Stage III-IV

59

21

35.6

  
  1. *p < 0.05